Investors in funds with exposure to Danish pharmaceutical giant Novo Nordisk are likely to keep holding their breath through 2018, as the company potentially shifts towards solutions that do not require injections by users of its products. The company, which employs over 42,000 staff, manufactures on five continents and sells in over 170 countries, is […]
Novo Nordisk, the Danish copmany best known for diabetes treatments, and which has over 42,000 employees globally, has been tipped for additional annual sales of up to $10bn within five years of launch of an oral version of its Semaglutide medication – if it is able to make a pill. The forecast has come from […]
Insulin maker Novo Nordisk has replaced Statoil as the biggest Nordic company by market cap, according to reports in Danish and Norwegian media.